Effect of the Interaction Between an Ionic Surfactant and Polymer on the Dissolution of a Poorly Soluble Drug
- 94 Downloads
Surfactants are commonly incorporated in conventional and enabled formulations to enhance the rate and extent of dissolution of drugs exhibiting poor aqueous solubility. Generally the interactions between the drug and excipients are systematically evaluated, however, limited attention is paid towards understanding the effect of interaction between functional excipients and its impact on the performance of the product. In the current study, the effect of potential interaction between a nonionic polymer binder, povidone, and anionic surfactant docusate sodium on the rate and extent of dissolution of a drug exhibiting poor aqueous solubility was evaluated by varying the proportions of the binder and the surfactant in the formulation. Potential complexation or aggregation between the excipients was investigated by fluorescence spectroscopy and zeta potential measurements of the aqueous solutions of docusate sodium, povidone, and sodium lauryl sulfate (SLS). The rate and extent of drug release was found to decrease with an increase in the proportion of docusate sodium and povidone in the formulations. Difference in magnitude of surface charge (zeta potential) of docusate sodium in presence of povidone indicated potential surfactant-polymer aggregation during dissolution which was corroborated by CAC/CMC values derived from fluorescence spectroscopic measurements. The decrease in the rate of drug release was attributed to an increase in the viscosity of the microenvironment of dissolving particles due to the interaction of docusate sodium and povidone in the aqueous media during dissolution. These findings highlight the importance of systematic evaluation of the interaction of ionic surfactants with the polymeric components within the formulation to ensure the appropriate selection of the type of surfactant as well as its proportion in the formulation.
KEY WORDSpolyvinylpyrrolidone docusate sodium sodium lauryl sulfate dissolution anionic surfactants polymer-surfactant aggregation
- SLS Sodium lauryl sulfate
DS Docusate sodium
- 9.Shah SH, Patel VR, Shah VR, Vaghani ZH, Thakkar AY. Nanotechnology: a review on revolution in cancer treatment. Pharm Rev. 2008;6(6).Google Scholar
- 20.de Martins RM, Silva CA, Becker C, Samios D, Bica CID, Christoff M. Studies on anionic surfactant structure in the aggregation with (hydroxypropyl)cellulose. Polimeros. 2002;12:109–14.Google Scholar
- 22.Ghebremeskel AN, Vemavarapu C, Lodaya M. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: selection of polymer–surfactant combinations using solubility parameters and testing the processability. Int J Pharm. 2007;328(2):119–29.CrossRefPubMedPubMedCentralGoogle Scholar
- 29.US FDA. Inactive ingredient search for approved drug products 2018 [cited 2018 5/1/2018]. Available from: http://www.accessdata.fda.gov/scripts/cder/iig/.